Christian Kanstrup, SVP Biopharm Operations, joined Novo Nordisk in 1999 as Assistant Treasurer in Corporate Treasury. In 2002, Christian took up the role as Investor Relations Manager at the Global headquarter in Denmark and was, from 2004-05, Director of Investor Relations, North America, based in Princeton, New Jersey. From 2005-2010, as CVP of Corporate Strategy and Business Development, Christian was responsible for the overall corporate strategy, M&A as well as licensing and collaborations. From 2011-2013, Christian was head of Finance, Legal and IT for Region Japan and Korea based in Tokyo, Japan. From 2013-2015, Christian, in his role as SVP Region China based in Beijing, China, was responsible for commercial operations in mainland China, Taiwan and Hong Kong. In August 2015, Christian returned to headquarter in Denmark as SVP Marketing, Medical Affairs and Stakeholder Engagement. In October 2017, Christian took up the position as SVP and Head of Biopharm Operations.
In his current role Christian works extensively with key stakeholders across the haemophilia community and is responsible for ensuring the Novo Nordisk haemophilia portfolio is made accessible to patients around the world.
Christian was elected Vice President of the Novo Nordisk Haemophilia Foundation Council in November 2017.